Agiomix announces its 100% compliance with the College of American Pathologists (CAP) proficiency testing for hepatitis B virus (HBV)
Agiomix, a regional accredited lab for molecular and genetic testing, is proud to announce that, further to its accreditation in next generation sequencing, it has fulfilled the CAP proficiency testing requirements for molecular diagnostics. In addition, its result for hepatitis B virus (HBV) was 100% compliant with CAP proficiency testing.
Dr. Salah Al Janabi, Managing Director at Agiomix, commented “Agiomix is committed to providing its customers with the most accurate results for their testing. We are continuously participating in CAP proficiency testing to ensure that results provided to our customers are 100% accurate.”